Search Results - "O'Connell, Kara E"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine by O'Connell, Kara E, Thakore, Jogin, Dev, Kumlesh K

    Published in Schizophrenia research (01-06-2014)
    “…Abstract Background We have previously shown that the neurotrophic factor, S100B, is raised in serum samples of female patients with schizophrenia, but not…”
    Get full text
    Journal Article
  2. 2
  3. 3

    In vitro and ex vivo models of multiple sclerosis by Madill, Martin, Fitzgerald, Denise, O’Connell, Kara E., Dev, Kumlesh K., Shen, Sanbing, FitzGerald, Una

    Published in Drug discovery today (01-09-2016)
    “…•Boosting remyelination and nerve repair should be a property of novel MS therapies.•Primary oligodendrocyte and brain slice cultures could accelerate MS drug…”
    Get full text
    Journal Article
  4. 4

    A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson’s disease by Dutta, Priyanka, Dargahi, Leila, O’Connell, Kara E., Bolia, Ashini, Ozkan, Banu, Sailer, Andreas W., Dev, Kumlesh K.

    Published in Neuroscience letters (23-04-2018)
    “…[Display omitted] •PAEL receptor interacts with GABARAPL2.•GABARAPL2 modulates levels of PAEL receptor.•In silico modelling supports PAEL receptor interaction…”
    Get full text
    Journal Article
  5. 5

    The protein interacting with C‐kinase (PICK1) interacts with and attenuates parkin‐associated endothelial‐like (PAEL) receptor‐mediated cell death by Dutta, Priyanka, O'Connell, Kara E., Ozkan, Sefika B., Sailer, Andreas W., Dev, Kumlesh K.

    Published in Journal of neurochemistry (01-08-2014)
    “…The parkin‐associated endothelial‐like receptor (PAELR, GPR37) is an orphan G protein‐coupled receptor that interacts with and is degraded by parkin‐mediated…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication by O’Connell, Kara E., Thakore, Jogin, Dev, Kumlesh K.

    Published in Cytokine (Philadelphia, Pa.) (01-05-2015)
    “…•We examine IL23 levels in patients with schizophrenia compared to controls.•These levels were correlated with treatment time, age and illness severity.•IL23…”
    Get full text
    Journal Article
  8. 8

    The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients by O'Connell, Kara E., Mok, Tzehow, Sweeney, Brian, Ryan, Aisling M., Dev, Kumlesh K.

    Published in Autoimmunity (Chur, Switzerland) (01-12-2014)
    “…Abstract Multiple sclerosis (MS) is an inflammatory illness characterized by demyelination and axonal neurodegeneration. Here, we used serum samples from MS…”
    Get full text
    Journal Article
  9. 9

    The spectrum of psychosis in multiple sclerosis: a clinical case series by Gilberthorpe, Thomas G, O'Connell, Kara E, Carolan, Alison, Silber, Eli, Brex, Peter A, Sibtain, Naomi A, David, Anthony S

    Published in Neuropsychiatric disease and treatment (01-01-2017)
    “…Psychosis in the context of multiple sclerosis (MS) has previously been reported as a rare occurrence. However, recent epidemiological studies have found…”
    Get full text
    Journal Article